UroGen Pharma Ltd. URGN
34.40 USD +0.04 (+0.12%)
At closeNov 3, 2026, 4:00 PM EST
34.40 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
34.00 Day range 34.97
16.50 52-week range 50.81
- YTD
- +46.88%
- 1 year
- +66.83%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 109.79M | 90.40M | 82.71M | 64.36M | 48.04M | |
| 97.34M | 81.52M | 73.35M | 56.70M | 42.88M | |
| -124.86M | -96.78M | -65.54M | -79.04M | -92.29M | |
| -153.49M | -126.87M | -102.24M | -109.78M | -110.82M | |
| -3.19 | -2.96 | -3.55 | -4.81 | -4.96 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 112.09M | 173.06M | 95.82M | 56.22M | 45.59M | |
| 200.46M | 285.71M | 178.31M | 135.62M | 119.75M | |
| 305.93M | 294.51M | 243.52M | 224.98M | 111.33M | |
| 130.09M | 123.39M | 99.39M | 99.12M | 398.00K | |
| -105.47M | -8.80M | -65.21M | -89.36M | 8.41M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -162.44M | -96.77M | -76.38M | -87.56M | -84.89M | |
| 61.56M | -20.61M | -953.00K | 1.06M | 4.07M | |
| 39.92M | 194.62M | 116.93M | 97.13M | 72.32M | |
| -289.00K | -295.00K | -194.00K | -254.00K | -752.00K | |
| -60.97M | 77.24M | 39.60M | 10.63M | -8.50M |